Lazard Asset Management LLC Atri Cure, Inc. Transaction History

Lazard Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$19.86 - $29.09 $30,385 - $44,507	1,530 Added 108.51%	2,940 $66,000
Q1 2024 May 14, 2024	SELL	$28.21 - $37.78 $63,472 - $85,005	-2,250 Reduced 61.48%	1,410 $42,000
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $4,156 - $5,449	126 Added 3.57%	3,660 $130,000
Q3 2023 Nov 14, 2023	BUY	$41.12 - $57.73 $70,561 - $99,064	1,716 Added 94.39%	3,534 $154,000
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $15,912 - $21,889	416 Added 29.67%	1,818 $71,000
Q2 2022 Aug 09, 2022	BUY	$35.1 - $66.01 $49,210 - $92,546	1,402 New	1,402 $57,000
Q4 2021 Feb 09, 2022	SELL	$63.4 - $87.14 $934,769 - $1.28 Million	-14,744 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$69.28 - $84.46 $1.02 Million - $1.25 Million	14,744 New	14,744 $1.03 Million

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.66B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.